FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Gludopa, 52370-58-8, Gludopa Intermediate 56-85-9, stock 934.7g, white powder, assay by HPLC 99.2%, HNMR, LCMS we supply. |
Gludopa, 52370-58-8, Gludopa Intermediate 59-92-7, stock 278.6g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
Gludopa, 52370-58-8, Gludopa Intermediate 52370-58-8, stock 675.1g, white powder, assay by HPLC 98.4%, HNMR, LCMS we supply. |